Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bejon

Showing results (161-170 of 276) with videos related to

Pageof 28
Sort By:
AAS Open Research|February 5, 2019
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, UgandaAlison M Elliott, Meta Roestenberg, Anne Wajja, et al.
Plos One|September 11, 2025
Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patientsPerpetual Wanjiku, Benedict Orindi, John Kimotho, et al.
Wellcome Open Research|July 17, 2023
Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host <i>P. falciparum</i> diversity throughout treatment in a clinical drug trialKevin Wamae, Leonard Ndwiga, Oksana Kharabora, et al.
Elife|March 14, 2023
<i>Plasmodium falciparum</i> adapts its investment into replication <i>versus</i> transmission according to the host environmentAbdirahman I Abdi, Fiona Achcar, Lauriane Sollelis, et al.
Trials|December 23, 2015
Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialHo Kwong Li, Matthew Scarborough, Rhea Zambellas, et al.
Scientific Reports|November 3, 2025
Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western KenyaVictor Osoti, Kevin Wamae, Moses M Musau, et al.
Haematologica|September 9, 2021
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal <i>Salmonella</i> bacteremiaKelvin M Abuga, John Muthii Muriuki, Sophie M Uyoga, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraDaniel P Webster, Susanna Dunachie, Jenni M Vuola, et al.
Science (New York, N.Y.)|August 20, 2021
Malaria infection and severe disease risks in AfricaRobert S Paton, Alice Kamau, Samuel Akech, et al.
Wellcome Open Research|March 22, 2022
Individual-level variations in malaria susceptibility and acquisition of clinical protectionJohn Joseph Valletta, John W G Addy, Adam J Reid, et al.
Pageof 28

Showing results (161-170 of 276) with videos related to

Sort By:
Pageof 28
AAS Open Research|February 5, 2019
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, UgandaAlison M Elliott, Meta Roestenberg, Anne Wajja, et al.
Plos One|September 11, 2025
Induction of an early IFN-γ cellular response and high plasma levels of SDF-1α are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patientsPerpetual Wanjiku, Benedict Orindi, John Kimotho, et al.
Wellcome Open Research|July 17, 2023
Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host <i>P. falciparum</i> diversity throughout treatment in a clinical drug trialKevin Wamae, Leonard Ndwiga, Oksana Kharabora, et al.
Elife|March 14, 2023
<i>Plasmodium falciparum</i> adapts its investment into replication <i>versus</i> transmission according to the host environmentAbdirahman I Abdi, Fiona Achcar, Lauriane Sollelis, et al.
Trials|December 23, 2015
Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trialHo Kwong Li, Matthew Scarborough, Rhea Zambellas, et al.
Scientific Reports|November 3, 2025
Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western KenyaVictor Osoti, Kevin Wamae, Moses M Musau, et al.
Haematologica|September 9, 2021
Hepcidin regulation in Kenyan children with severe malaria and non-typhoidal <i>Salmonella</i> bacteremiaKelvin M Abuga, John Muthii Muriuki, Sophie M Uyoga, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraDaniel P Webster, Susanna Dunachie, Jenni M Vuola, et al.
Science (New York, N.Y.)|August 20, 2021
Malaria infection and severe disease risks in AfricaRobert S Paton, Alice Kamau, Samuel Akech, et al.
Wellcome Open Research|March 22, 2022
Individual-level variations in malaria susceptibility and acquisition of clinical protectionJohn Joseph Valletta, John W G Addy, Adam J Reid, et al.
Pageof 28